drugset / Trial / NCT05169450
Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized positived-controlled study of Diterpene Ginkgolides Meglumine Injection (DGMI) vs Ginaton in patients with ischemic stroke (IS) was conducted between7/2013 and 4/2014. The study was designed to test efficacy of DGMI for IS. Post hoc analysis of this trial was conducted to evaluate the efficacy of DGMI in elderly (aged≥65 years) IS patients.
Timeline
- Start
- 2013-07-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diterpene ginkgolides meglumine injection | Unknown | 25 mg | Intravenous |
| Comparator | Ginaton | Unknown | 35 mg | Intravenous |
| Comparator | Ginaton | Unknown | 60 mg | Intravenous |